SKI Market

Indian Indices

Sensex

78,038.83 472.67
( 0.61%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

54,146.56 1,417.84
(2.69%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.85 0.10
(0.11%)

EUR-INR

106.60 0.13
(0.12%)

GBP-INR

123.04 0.62
(0.51%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

34.78

686.83

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.26

Back

radhagobind commercial ltd

Prima Industries reports consolidated net loss of Rs 0.04 crore in the September 2025 quarter

Nov 13,2025

Net Loss of Prima Industries reported to Rs 0.04 crore in the quarter ended September 2025 as against net loss of Rs 0.22 crore during the previous quarter ended September 2024. Sales declined 8.72% to Rs 1.78 crore in the quarter ended September 2025 as against Rs 1.95 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1.78	1.95	-9
OPM %	1.69	-3.08	-
PBDT	0.03	-0.06	LP
PBT	-0.04	-0.22	82
NP	-0.04	-0.22	82

78,038.83 472.67 ( 0.61%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

54,146.56 1,417.84 (2.69%)

10,249.54 -35.21 (-0.34%)

91.85 0.10 (0.11%)

106.60 0.13 (0.12%)

123.04 0.62 (0.51%)

0.58 0.00 (-0.25%)